Skip to main content
Advertisement
  • Other Publications
    • EMBO Press
    • EMBO reports (Home)
    • The EMBO Journal
    • EMBO Molecular Medicine
    • Molecular Systems Biology
    • Life Science Alliance
Login

   

Search

Advanced Search

Journal

  • Home
  • Latest Online
  • Current Issue
  • Archive
  • Subject Collections
  • Review Series & Focuses

Authors & Referees

  • Submit
  • Author Guidelines
  • Aims & Scope
  • Editors & Board
  • Transparent Process
  • Bibliometrics
  • Referee Guidelines
  • Open Access

Info

  • E-Mail Editorial Office
  • Alerts
  • RSS Feeds
  • Subscriptions & Access
  • Reprints & Permissions
  • Advertise & Sponsor
  • Media Partners
  • News & Press
  • Recommend to Librarian
  • Customer Service
  • Home
  • Latest Online

Science & Society

The dilemmas of science for policy

Scientific evidence and the consequences of regulatory options in risk and benefit assessment
View ORCID ProfileJosé Luis Luján, Oliver Todt
DOI 10.15252/embr.201744795 | Published online 05.01.2018
EMBO reports (2018) e44795
José Luis Luján
Department of Philosophy University of the Balearic Islands, Palma, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oliver Todt
Department of Philosophy University of the Balearic Islands, Palma, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site

Author Affiliations

  1. José Luis Luján (jl.lujan{at}uib.es)1 and
  2. Oliver Todt1
  1. 1Department of Philosophy University of the Balearic Islands, Palma, Spain
View Abstract
  • Article
  • Transparent Process
Loading

Regulatory decision‐making often faces the question of what is an appropriate level of evidence. For instance, which approach is better suited to regulate potentially toxic chemicals: obtaining the best—most complete, most accurate, and so on—information that science is able to produce on each individual compound or relying on more basic knowledge to quickly assess a wide range of compounds? The first one would appear as the obvious answer, but, given the time and resource constraints under which regulators often operate, it may not be the most efficient one. Gathering the most complete and accurate scientific information means that regulatory agencies would be able to deal with only a limited number of substances. In contrast, by limiting the required evidence, they might be able to regulate many more substances albeit at the risk of sometimes making wrong decisions.

The key issue is how to establish the appropriate level of evidence for regulatory purposes and to choose the scientific methodologies best suited for generating this evidence.

This is a typical dilemma faced by regulatory agencies in many areas, and the example above is the cause of ongoing controversy among regulators, manufacturers, environmentalists, and public health advocacy groups. The key issue is how to establish the appropriate level of evidence for regulatory purposes and to choose the scientific methodologies best suited for generating this evidence.

Another example shows how the same dilemma befalls the field of benefit assessment. Many foods with health claims assert that certain ingredients will confer health benefits for consumers, beyond the nutritional characteristics. Again, what is the appropriate regulatory strategy: to analyze the product in question using the most accurate and complete scientific methodologies at hand, even if that means that only a small number of products will achieve authorization? Or recurring to basic or incomplete scientific information, to …

View Full Text

Subscribers, please sign in with your username and password.

Log in using your username and password

Enter your EMBO Reports username.
Enter the password that accompanies your username.
Forgot your user name or password?

Log in through your institution

You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.

Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00

Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.

EMBO Members please login here to access the journals

Subscribe to the Journal

EMBO Journal

EMBO Reports

Recommend to your Librarian

EMBO Journal

EMBO Reports

 

 

Next Article in this Issue
Back to top

  • PDF
  • Share
  • Export
  • Print
Loading

PDF

In this Issue
Volume 19, Issue 4
01 April 2018 | pp -
EMBO reports: 19 (4)
About the cover
Alert me when this article is cited
Alert me if a correction is posted

Article

  • Article
    • Regulatory dilemmas and methodological controversies
    • Population‐level dimensions of regulatory options
    • Conclusion
    • Conflict of interest
    • Acknowledgements
    • References
  • Transparent Process

Related Content

More Science & Society

  • Improving animal research reporting standards
    Nikki Osborne, Marc T Avey, Lida Anestidou, Merel Ritskes‐Hoitinga, Gilly Griffin
    EMBO reports : e46069
  • Science, politics and ideologies
    Philip Hunter
    EMBO reports : e46130
  • Synthetic gene drive: between continuity and novelty
    Samson Simon, Mathias Otto, Margret Engelhard
    EMBO reports : e45760
More Science & Society

Related Articles

Cited By...

Request Permissions

Subject Areas

  • S&S: Ecosystems & Environment
  • S&S: Health & Disease
  • S&S: Politics, Policy & Law

Journal

  • Latest Online
  • Current Issue
  • Archive
  • Bibliometrics
  • E-Mail Editorial Office

Authors & References

  • Aims & Scope
  • Editors & Board
  • Transparent Process
  • Author Guidelines
  • Referee Guidelines
  • Open Access
  • Submit

Info

  • Alerts
  • RSS Feeds
  • Subscriptions & Access
  • Reprints & Permissions
  • Advertise & Sponsor
  • News & Press
  • Recommend to Librarian
  • Customer Service

EMBO

  • Funding & Awards
  • Events
  • Science Policy
  • Members
  • About EMBO

Online ISSN  1469-3178

Copyright© 2018 EMBO

This website is best viewed using the latest versions of all modern web browsers. Older browsers may not display correctly.